Medicine and Dentistry
Pediatrics
100%
Inflammatory Bowel Disease
90%
Crohn's Disease
63%
Ulcerative Colitis
52%
Disease
48%
Pediatrics Patient
29%
Fecal Microbiota Transplantation
25%
Infliximab
24%
Immunomodulating Agent
16%
Infection
13%
Clostridium Difficile Infection
12%
Cohort Analysis
12%
Mesalazine
12%
Disease Course
11%
Colitis
11%
Odds Ratio
10%
Percutaneous Endoscopic Gastrostomy
9%
Symptom
8%
Patient with Crohn's Disease
8%
Disease Activity
8%
Adolescent
7%
Patient with Inflammatory Bowel Disease
7%
Prevalence
7%
Disease Severity
7%
Gastrointestinal Distress
7%
Tumor Necrosis Factor
7%
Drug Therapy
6%
Corticosteroid Therapy
6%
Peptoclostridium difficile
6%
Magnetic Resonance Enterography
6%
Gastrostomy
5%
Microbiome
5%
TNF Inhibitor
5%
Gene Expression
5%
Diarrhea
5%
Body Mass Index
5%
Combination Therapy
5%
Keyphrases
Inflammatory Bowel Disease
56%
Crohn's Disease
39%
Ulcerative Colitis
29%
Clostridium Difficile Infection
23%
Fecal Microbiota Transplantation
22%
Pediatric Inflammatory Bowel Disease
19%
Pediatric Patients
18%
Infliximab
18%
Pediatric Crohn's Disease
16%
Newly Diagnosed
15%
Pediatric Ulcerative Colitis
14%
Infections in children
11%
Corticosteroids
10%
North America
10%
Inception Cohort Study
10%
Clostridioides Difficile
9%
Immunomodulator
9%
Pediatric
8%
Disease Phenotype
8%
Extraintestinal Manifestations
8%
African American
7%
Gastrointestinal Diseases
7%
Odds Ratio
7%
Clinical Course
6%
Disease Pattern
6%
Pediatric Population
6%
Working Diagnosis
6%
Very Early-onset Inflammatory Bowel Disease
6%
Nutritional Considerations
6%
Infliximab Therapy
6%
MR Enterography
6%
Nutritional Management
6%
Disease Severity
6%
Stricture
5%
Mesalazine
5%
Thiopurines
5%
Inception Cohort
5%
Thiopurine Immunomodulators
5%
